Shanghai Aladdin Biochemical Technology Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 265.64 million compared to CNY 197.57 million a year ago. Revenue was CNY 265.64 million compared to CNY 197.57 million a year ago.

Net income was CNY 65.54 million compared to CNY 59.54 million a year ago. Basic earnings per share from continuing operations was CNY 0.3286 compared to CNY 0.301 a year ago. Diluted earnings per share from continuing operations was CNY 0.3286 compared to CNY 0.301 a year ago.